Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9311692 | Urology | 2005 | 5 Pages |
Abstract
Early experience with pRFA for renal tumor seems promising, but patient selection criteria are evolving. On the basis of our limited experience, we recommend caution when using renal pRFA in patients with prior partial nephrectomy, multiple tumors treated in the same setting, and tumors located anteriorly or centrally. Further clinical experience will help establish guidelines for the use of this powerful technology in the management of renal tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alon Z. Weizer, Ganesh V. Raj, Martin O'Connell, Cary N. Robertson, Rendon C. Nelson, Thomas J. Polascik,